CAVIN1 Chromosome 17
Caveolae associated protein 1
Upload your DNA to see your personal genotypes for variants in CAVIN1.
What This Gene Does
This gene encodes a protein that enables the dissociation of paused ternary polymerase I transcription complexes from the 3' end of pre-rRNA transcripts. This protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. This protein also localizes to caveolae at the plasma membrane and is thought to play a critical role in the formation of caveolae and the stabilization of caveolins. This protein translocates from caveolae to the cytoplasm after insulin stimulation. Caveolae contain truncated forms of this protein and may be the site of phosphorylation-dependent proteolysis. This protein is also thought to modify lipid metabolism and insulin-regulated gene expression. Mutations in this gene result in a disorder characterized by generalized lipodystrophy and muscular dystrophy. [provided by RefSeq, Nov 2009]
Gene Info
Gene Group
Cavins
Locus Type
gene with protein product
Location
17q21.2
Ensembl
ENSG00000177469
Associated Conditions (5)
Congenital generalized lipodystrophy type 4
CAVIN1-related disorder
Monogenic diabetes
See cases
Congenital generalized lipodystrophy
Key Variants
RS139531639
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4
Health Risk
RS143511306
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4
Health Risk
RS146547678
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4
Health Risk
RS146799286
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, Monogenic diabetes, CAVIN1-related disorder
Health Risk
RS148239625
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, Monogenic diabetes, Congenital generalized lipodystrophy type 4
Health Risk
RS185645510
Conflicting classifications of pathogenicity
Monogenic diabetes, Monogenic diabetes
Health Risk
RS200409122
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4
Health Risk
RS2085559084
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4
Health Risk
RS537998274
Conflicting classifications of pathogenicity
Monogenic diabetes, See cases, CAVIN1-related disorder
Health Risk
RS61729285
Conflicting classifications of pathogenicity
Monogenic diabetes, Congenital generalized lipodystrophy type 4, CAVIN1-related disorder
Health Risk
RS750373957
Conflicting classifications of pathogenicity
Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4
Health Risk
RS1555588981
Likely pathogenic
Health Risk
All Variants (26)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS139531639 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4 |
| RS143511306 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4 |
| RS146547678 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4 |
| RS146799286 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, Monogenic diabetes, CAVIN1-related disorder |
| RS148239625 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, Monogenic diabetes, Congenital generalized lipodystrophy type 4 |
| RS185645510 | Health Risk | Conflicting classifications of pathogenicity | Monogenic diabetes, Monogenic diabetes |
| RS200409122 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4 |
| RS2085559084 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS537998274 | Health Risk | Conflicting classifications of pathogenicity | Monogenic diabetes, See cases, CAVIN1-related disorder |
| RS61729285 | Health Risk | Conflicting classifications of pathogenicity | Monogenic diabetes, Congenital generalized lipodystrophy type 4, CAVIN1-related disorder |
| RS750373957 | Health Risk | Conflicting classifications of pathogenicity | Congenital generalized lipodystrophy type 4, CAVIN1-related disorder, Congenital generalized lipodystrophy type 4 |
| RS1555588981 | Health Risk | Likely pathogenic | — |
| RS199720089 | Health Risk | Likely pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS2509863445 | Health Risk | Likely pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS2509875985 | Health Risk | Likely pathogenic | CAVIN1-related disorder, CAVIN1-related disorder |
| RS1427062799 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1489315815 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1567776490 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1567776514 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1567782465 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1567782493 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS2509876602 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS2509876910 | Health Risk | Pathogenic | Congenital generalized lipodystrophy, Congenital generalized lipodystrophy |
| RS779638046 | Health Risk | Pathogenic | — |
| RS866504928 | Health Risk | Pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |
| RS1207466199 | Health Risk | Pathogenic/Likely pathogenic | Congenital generalized lipodystrophy type 4, Congenital generalized lipodystrophy type 4 |